EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas
High-grade primary brain tumors possessed poor outcome due to invasiveness. Extracellular matrix metalloproteinase inducer (EMMPRIN) stimulates peri-tumoral fibroblasts to secrete matrix metalloproteinase and promote invasiveness. This study hypothesized that high-grade brain tumors overexpress EMMP...
Main Authors: | , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer US
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744650/ |
id |
pubmed-3744650 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-37446502013-08-16 EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas Tsai, Wen-Chiuan Chen, Ying Huang, Li-Chun Lee, Herng-Sheng Ma, Hsin-I Huang, Shih-Ming Sytwu, Huey-Kang Hueng, Dueng-Yuan Laboratory Investigation High-grade primary brain tumors possessed poor outcome due to invasiveness. Extracellular matrix metalloproteinase inducer (EMMPRIN) stimulates peri-tumoral fibroblasts to secrete matrix metalloproteinase and promote invasiveness. This study hypothesized that high-grade brain tumors overexpress EMMPRIN. Analyzing the public delinked database from the Gene Expression Omnibus profile, the results showed that the EMMPRIN mRNA level was higher in WHO grade IV (n = 81) than in grade III (n = 19, p < 0.0005) astrocytomas and non-tumor brain tissue controls (n = 23, p < 0.00001). The results of tissue microarray-based immunohistochemical (IHC) staining revealed that EMMPRIN levels positively correlated with WHO grades for astrocytomas (p = 0.008) and meningiomas (p = 0.048). EMMPRIN mRNA levels in conventional glioma cell lines (n = 36) was not less than those in glioma primary culture cells (n = 27) and glioblastoma stem-like cells (n = 12). The GBM8401, U87MG, and LN229 human glioma cell lines also overexpressed EMMPRIN. Hematoxylin and eosin, IHC, and immunofluorescence staining of xenografts confirmed that high-grade brain tumors overexpressed EMMPRIN. Lastly, Kaplan–Meier analysis revealed poorer survival in WHO grade IV (n = 56) than in grade III astrocytomas (n = 21, by log-rank test; p = 0.0001, 95 % CI: 1.842–3.053). However, in high-grade astrocytomas, there was no difference in survival between high and low EMMPRIN mRNA levels. Thus, this study identified that high-grade brain tumors overexpress EMMPRIN, which positively correlates with WHO grades in human astrocytomas and meningiomas, and suggests that EMMPRIN may be a therapeutic target of brain tumor. Springer US 2013-07-02 2013 /pmc/articles/PMC3744650/ /pubmed/23817808 http://dx.doi.org/10.1007/s11060-013-1184-5 Text en © The Author(s) 2013 Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Tsai, Wen-Chiuan Chen, Ying Huang, Li-Chun Lee, Herng-Sheng Ma, Hsin-I Huang, Shih-Ming Sytwu, Huey-Kang Hueng, Dueng-Yuan |
spellingShingle |
Tsai, Wen-Chiuan Chen, Ying Huang, Li-Chun Lee, Herng-Sheng Ma, Hsin-I Huang, Shih-Ming Sytwu, Huey-Kang Hueng, Dueng-Yuan EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas |
author_facet |
Tsai, Wen-Chiuan Chen, Ying Huang, Li-Chun Lee, Herng-Sheng Ma, Hsin-I Huang, Shih-Ming Sytwu, Huey-Kang Hueng, Dueng-Yuan |
author_sort |
Tsai, Wen-Chiuan |
title |
EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas |
title_short |
EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas |
title_full |
EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas |
title_fullStr |
EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas |
title_full_unstemmed |
EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas |
title_sort |
emmprin expression positively correlates with who grades of astrocytomas and meningiomas |
description |
High-grade primary brain tumors possessed poor outcome due to invasiveness. Extracellular matrix metalloproteinase inducer (EMMPRIN) stimulates peri-tumoral fibroblasts to secrete matrix metalloproteinase and promote invasiveness. This study hypothesized that high-grade brain tumors overexpress EMMPRIN. Analyzing the public delinked database from the Gene Expression Omnibus profile, the results showed that the EMMPRIN mRNA level was higher in WHO grade IV (n = 81) than in grade III (n = 19, p < 0.0005) astrocytomas and non-tumor brain tissue controls (n = 23, p < 0.00001). The results of tissue microarray-based immunohistochemical (IHC) staining revealed that EMMPRIN levels positively correlated with WHO grades for astrocytomas (p = 0.008) and meningiomas (p = 0.048). EMMPRIN mRNA levels in conventional glioma cell lines (n = 36) was not less than those in glioma primary culture cells (n = 27) and glioblastoma stem-like cells (n = 12). The GBM8401, U87MG, and LN229 human glioma cell lines also overexpressed EMMPRIN. Hematoxylin and eosin, IHC, and immunofluorescence staining of xenografts confirmed that high-grade brain tumors overexpressed EMMPRIN. Lastly, Kaplan–Meier analysis revealed poorer survival in WHO grade IV (n = 56) than in grade III astrocytomas (n = 21, by log-rank test; p = 0.0001, 95 % CI: 1.842–3.053). However, in high-grade astrocytomas, there was no difference in survival between high and low EMMPRIN mRNA levels. Thus, this study identified that high-grade brain tumors overexpress EMMPRIN, which positively correlates with WHO grades in human astrocytomas and meningiomas, and suggests that EMMPRIN may be a therapeutic target of brain tumor. |
publisher |
Springer US |
publishDate |
2013 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744650/ |
_version_ |
1612003417358598144 |